Sunday , November 17 2019
Home / argentina / A group of scientists believes they have the key to the ultimate cure for cancer.

A group of scientists believes they have the key to the ultimate cure for cancer.

Cancer is one of the major causes of death in the world. According to the World Health Organization (WHO), 1 out of 5 men and 1 out of 6 women are currently suffering, and in 2018, 9.6 million people died from this disease in the world.

There are several treatments that are trying to eradicate cancer, but so far there is no one who would finally do away with this condition.

Recently it was reported that a group of Israeli scientists from the pharmaceutical laboratory Accelerated Biotech Evolution (AEBi) can change our view of cancer, since, as they announced, they are very close to determining a much more effective treatment than the current ones to establish this disease.

“We believe that in a year we will offer a complete cure for cancer,” he said. Dan Aridor, president of AEBi.

“It will be effective from day one, last for several weeks and will have minimal side effects or not at all at a much lower cost than most other treatments on the market,” he added.

According to The Jerusalem Post, this treatment, known as “MuTaTo” (multipurpose toxin), is an antibiotic that is a combination of toxins that specifically attack cancer cells and eliminate the possibility of the disease reappearing. ,

From my side Ilan MoradThe study leader told the Israeli channel that the experts would be responsible for analyzing the type of cancer of each patient in order to be able to provide an antibiotic specifically designed to treat their disease.

That is, although it is intended for general treatment, cancer treatment with MuTaTo will be designed specifically for each person, analyzing samples of each biopsy.

Morad compared the MuTaTo concept with a triple drug that helped change AIDS from an automatic death sentence to a chronic disease.

But unlike HIV and AIDS, where patients must constantly take medication using MuTaTo, the cells will be killed, so treatment can be stopped in just a few weeks.

As expected, This ad provoked all sorts of reactions, and there are those who accept these statements with skepticism, indicating that the study is limited and does not have any scientific publication to support it.

One of them is Len Lichtenfeldthe director of the American Cancer Society, who says that it is too early to conclude that the drug will work successfully in humans, because so far it has only been tested on mice.

“Unfortunately, we should know that this is far from an effective treatment for people with cancer and, especially, a cure,” he wrote in his personal blog.

Source link